Şunu aradınız:: ihc (Slovakça - İngilizce)

imunohistochemická (ihc) metóda;
the immunohistochemical (ihc) method;

hlavnou testovacou metódou na stanovenie her2 pozitivity v tejto pilotnej štúdii bola imunohistochémia (ihc).
the main test method used to determine her2 positivity in this pivotal study was immunohistochemistry (ihc).

expresia pd-l1 v nádore sa stanovila pomocou analýzy pd-l1 ihc 28-8 pharmdx.
tumour pd-l1 expression was determined using the pd-l1 ihc 28-8 pharmdx assay.

u 45% pacientov so známou expresiou egfr boli hodnoty pomeru rizika 0, 68 (is 0, 49- 0, 94) u pacientov s egfr- pozitívnymi karcinómami a 0, 93 (is 0, 63- 1, 36) u pacientov s egfr- negatívnymi karcinómami (definované pomocou ihc použitím egfr pharmdx kitu a definovaním egfr - negativity menej ako 10% sfarbených nádorových buniek).
in the 45% of patients with known egfr-expression status, the hazard ratio was 0.68 (ci 0.49-0.94) for patients with egfr-positive tumours and 0.93 (ci 0.63-1.36) for patients with egfr-negative tumours (defined by ihc using egfr pharmdx kit and defining egfr-negative as less than 10% tumour cells staining).